Blood & Cancer
161 episodes - English - Latest episode: about 3 years ago - ★★★★★ - 31 ratingsThe official podcast feed of MDedge Hematology-Oncology, part of the Medscape Professional Network. On Thursdays, Dr. David Henry interviews key opinion leaders and rising stars in hematology and oncology. The information in this podcast is provided for informational and educational purposes only.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
KATHERINE trial and breast cancer
February 28, 2019 09:00 - 25 minutes - 23.5 MBCharles E. Geyer, MD, of Virginia Commonweath University joins guest host Jame Abraham, MD, of the Cleveland Clinic to discuss the KATHERINE trial and its impact on the treatment of HER2-positive breast cancer. And Ilana Yurkiewicz, MD, talks about whether it's better for physicians to be vague about prognosis. Show notes By Hitomi Hosoya, MD, PhD Resident in the department of internal medicine, University of Pennsylvania Health System The idea behind the KATHERINE trial was to dete...
How to read and review scientific papers
February 21, 2019 09:00 - 20 minutes - 34.1 MBDaniel G. Haller, MD, of the University of Pennsylvania joins David H. Henry, MD, to talk about the best ways to read and review the scientific literature. And Ilana Rachel Yurkiewicz, MD, talks about chaos and opportunity. Show notes By Hitomi Hosoya, MD, PhD, Resident in the department of internal medicine, University of Pennsylvania Health System - If you are a peer reviewer of a manuscript submitted to a journal, you should be unbiased, consistent, constructive, and focused on ...
ESMO 2018 and more
February 14, 2019 09:00 - 23 minutes - 38.5 MBDavid Henry, MD, welcomes Daniel G. Haller, MD, to rehash research from ESMO 2018 as well as the way the meeting itself was run. And Ilana Yurkiewicz, MD, stops by for this week’s Clinical Correlation. Dr. Yurkiewicz is a Hematology Fellow at Stanford and is also a columnist at MDedge Hematology/Oncology. More from Dr. Yurkiewicz here. Contact us: [email protected] MDedge on Twitter: @mdedgehemonc Dr. Ilana Yurkiewicz on Twitter: @ilanayurkiewicz SHOW NOTES By Emily Bryer, DO ...
Biosimilars: Gary Lyman
February 07, 2019 09:00 - 29 minutes - 46.9 MBIn this episode, Gary H. Lyman, MD (https://bitly.is/2UJzUly) joins David Henry, MD, (http://bit.ly/2MFDfzm) to talk about biosimilars. Dr. Lyman talks about the definition of biosimilars, how they are made, which are approved, and which ones are on the market. He also talks about extrapolation and interchangeability as well as where some biosimilars stand in both ASCO and NCCN guidelines for patients who are going into supportive care. And Ilana Yurkiewicz, MD (https://stanford...
Antiemetics: Richard Gralla
January 31, 2019 09:00 - 27 minutes - 43 MBIn the first episode of Blood & Cancer, David Henry, MD (http://bit.ly/2MFDfzm), welcomes Richard J. Gralla, MD (http://bit.ly/2ShsxEv), or the Albert Einstein College of Medicine in New York. The topic today centers around antiemetics and ways to use them. And later, Ilana Yurkiewicz, MD (https://stanford.io/2RXPixR), debuts her segment Clinical Correlations all about hematology care. Visit MDedge/hematology-oncology Show Notes By Emily Bryer, DO Highly emetic chemotherapy regimens ...
The JCSO Interview: Dr. Maura Sammon
August 07, 2018 19:12 - 17 minutes - 16.3 MBWhen cancer patients present to the emergency department with symptoms and say they’re being treated for cancer, it’s crucial for the attending physician to ascertain at the outset if the treatment is with chemotherapy or immunotherapy so that the appropriate symptom treatment can be initiated as early as possible. The key here is communication: first, between the oncologist and patient, so that the patient is aware of these nuances in advance of an emergency, and second, between the ED phys...
David Henry’s JCSO podcast, May - June 2018
August 03, 2018 12:28 - 14 minutes - 13.8 MBIn his bimonthly podcast, Dr Henry, the JCSO Editor-in-Chief, discusses a round-up by JCSO Editor Dr Howard Burris of the top takeaways from this year’s annual ASCO meeting, as well as a series of articles focusing on CAR T-cell therapies. He also looks at reports on psychosocial factors and treatment satisfaction after radical prostatectomy; the impact of inpatient rehabilitation on outcomes for patients with cancer; the long-term effects of posttreatment exercise on pain in young women wit...
David Henry’s JCSO podcast, March - April 2018
August 01, 2018 19:13 - 12 minutes - 11.4 MBIn his bimonthly podcast, Dr Henry, the JCSO Editor-in-Chief, discusses a round-up by JCSO Editor Dr Howard Burris of the top takeaways from this year’s annual ASCO meeting, as well as a series of articles focusing on CAR T-cell therapies. He also looks at reports on psychosocial factors and treatment satisfaction after radical prostatectomy; the impact of inpatient rehabilitation on outcomes for patients with cancer; the long-term effects of posttreatment exercise on pain in young women wit...
JCSO Interview with Dr Daniel Haller
March 29, 2018 18:16 - 26 minutes - 24.1 MBIn this interview, Dr David Henry, the Editor-in-Chief of The Journal of Community and Supportive Oncology, and Dr Daniel Haller of the Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine in Philadelphia, discuss recent breakthrough studies in gastrointestinal cancers.
JCSO Interview with Dr. Kenneth Anderson
March 27, 2018 18:51 - 31 minutes - 28.8 MBIn this interview, Dr David Henry, the Editor-in-Chief of The Journal of Community and Supportive Oncology, and Dr Ken Anderson, the Kraft Family Professor of Medicine at Harvard Medical School and an international thought leader and investigator in myeloma, discuss three cases of patients with myeloma that are indicative of the remarkable therapeutic advances in oncology in general, and in myeloma in particular. In the last 10-15 years, numerous approvals by the US Food and Drug Administrat...
JSCO Podcast January - February 2018
March 23, 2018 21:01 - 15 minutes - 24.9 MBIn this podcast, Dr Henry highlights research articles on analgesic management in radiation oncology for painful bone metastases, hospitalizations for fracture in patients with metastatic disease, measurement of physical activity and sedentary behavior in breast cancer survivors, and patient navigators’ personal experiences with cancer and their impact on treatment. He also discusses a New Therapies review article on hallmark tumor metabolism becoming a validated therapeutic target, as wel...